Sirona Biochem's current cash is $33K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Sirona Biochem's current cash stands at $33K as of July 2024. That compares with $310K in the prior-year period — down 89.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Sirona Biochem reported $33K in current cash versus $310K a year earlier — a 89.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $310K in the prior-year period — down 89.4% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Sirona Biochem's current cash evolved across reporting periods, while the comparison chart places SRBCF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, current cash is commonly used to spot outliers. Sirona Biochem's reading of $33K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.